Lung Cancers Completed Phase 2 Trials for Rubitecan (DB06159)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005872Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung CancerTreatment
NCT00006082Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung CancerTreatment